Genetics company receives $1.4 million NIH grant

The NIH has granted a total of $1,367,504 to 23andMe, a personal genetic testing company, for a 2-year project to enhance the company’s online database and research engine. The project will make access to aggregate, summary data available to outside researchers. Catherine Afarian, spokesperson for 23andMe, told HemOnc Today the company wants “the best and brightest minds in the world to have access” to their data. By granting access to outside experts, research that may have taken years to complete can be conducted quickly in real-time.

How do surgeons approach enhancements in refractive surgery patients?

CEDARS Debates is a monthly feature in Ocular Surgery News. CEDARS — Cornea, External Disease, and Refractive Surgery Society — is a group of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.As laser refractive surgery enters its third decade of widespread use in the U.S., an increasing number of patients are now returning for enhancements. LASIK patients, in particular, present the dilemma of how to approach the enhancement.